Clinical trial
Deep Learning in the Detection and Prediction of Hydroxychloroquine Maculopathy
NCT06839443 is registered in ClinicalTrials.gov with Centro Hospitalar de Lisboa Central as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Deep Learning in the Detection and Prediction of Hydroxychloroquine Maculopathy
- Lead sponsor
- Centro Hospitalar de Lisboa Central
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 1, 2024
- Completion date
- June 20, 2025
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hidroxicloroquine intake